ENTITY

Yichang HEC Changjiang Pharma (1558 HK)

83

Analysis

Health Care • Hong Kong

YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.

more

Refresh

Exchange Announcement • 25 Nov 2024 18:00

Sunshine Lake Pharma Co., Ltd. And Yichang Hec Changjiang Pharmaceutical Co., Ltd. To Enter Into A Licensing Agreement With Shenyang Sunshine Pharmaceutical., Ltd. To Commercialise Clifutinib Besylate

Exchange Announcement • 12 Nov 2024 21:40

Sunshine Lake Pharma Co., Ltd. To Enter Into A Licensing Agreement With Apollo To Develop And Commercialise Apl-18881 (Hec88473) , A Fgf21 / Glp-1 Dual Receptor Agonist

Exchange Announcement • 05 Nov 2024 21:00

Joint Announcement Monthly Update In Relation To The Proposed Pre-Conditional Privatisation Of Yichang Hec Changjiang Pharmaceutical Co., Ltd. By Sunshine Lake Pharma Co., Ltd. By Way Of Merger By Absorption Of Yichang Hec Changjiang Pharmaceutical Co., Ltd.

Exchange Announcement • 31 Oct 2024 19:03

Articles Of Association

Exchange Announcement • 31 Oct 2024 18:59

Poll Results Of 2024 First Extraordinary General Meeting Held On 31 October 2024

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.42.0

x